dorzolamide
Showing 1 - 25 of 87
Glaucoma, Open-Angle, Ocular Hypertension Trial in Argentina (Dorzolamide / Timolol Ophthalmic Solution, dorzolamide/timolol)
Recruiting
- Glaucoma, Open-Angle
- Ocular Hypertension
- Dorzolamide / Timolol Ophthalmic Solution
- dorzolamide/timolol
-
Olivos, Buenos Aires, Argentina
- +5 more
May 10, 2023
Glaucoma Trial in Gainesville (timolol maleate and dorzolamide HCl)
Completed
- Glaucoma
- timolol maleate and dorzolamide hydrochloride
-
Gainesville, FloridaUniversity of Florida
Dec 1, 2021
Diabetic Macular Edema Trial in Tehran (Injections of 1.25 mg of intravitreal bevacizumab with Timolol and Dorzolamide,
Active, not recruiting
- Diabetic Macular Edema
- Injections of 1.25 mg of intravitreal bevacizumab with Timolol and Dorzolamide
- Injections of 1.25 mg of intravitreal bevacizumab with artificial tears
-
Tehran, Iran, Islamic Republic ofOphthalmic Research Center
Oct 6, 2021
Primary Open-angle Glaucoma Trial in Bogotá, Zapopan (PRO-122, Timolol eye drops, Dorzolamide-Timolol Ophthalmic)
Recruiting
- Primary Open-angle Glaucoma
- PRO-122
- +6 more
-
Bogotá, Bogotá D.C., Colombia
- +1 more
Dec 22, 2021
Glaucoma, Open-Angle, Ocular Hypertension Trial in Monterrey (Dorzolamide-timolol-brimonidine and latanoprost,
Recruiting
- Glaucoma, Open-Angle
- Ocular Hypertension
- Dorzolamide-timolol-brimonidine and latanoprost
- Dorzolamide-timolol and latanoprost
-
Monterrey, MexicoServicios Médicos y de Investigación Clínica InspirePharma S. de
Dec 22, 2021
Glaucoma, Glaucoma Eye, Glaucoma, Open-Angle Trial in San Antonio (dietary supplement, drug, other)
Withdrawn
- Glaucoma
- +2 more
- Lumega-Z
- +2 more
-
San Antonio, TexasOphtalmology Clinic of William E Sponsel
Sep 30, 2022
Retinal Degenerations Trial in Chicago (2% dorzolamide)
Completed
- Retinal Degenerations
- 2% dorzolamide
-
Chicago, IllinoisUniversity of Illinois Medical Center
Oct 17, 2021
Glaucoma Trial in Miami (Latanoprost, Bimatoprost, Travoprost)
Active, not recruiting
- Glaucoma
- Latanoprost
- +7 more
-
Miami, FloridaBascom Palmer Eye Institute - University of Miami
Oct 7, 2021
Open-angle Glaucoma Trial in Thessaloniki (Drug: dorzolamide/timolol, Drug: latanoprost/timolol, dorzolamide/timolol and
Completed
- Open-angle Glaucoma
- Drug: dorzolamide/timolol
- +3 more
-
Thessaloniki, GreeceGlaucoma Unit, A University Dept of Ophthalmology
Dec 16, 2020
Glaucoma, Ocular Surface Disease Trial (tafluprost, tafluprost and dorzolamide/timolol)
Completed
- Glaucoma
- Ocular Surface Disease
- tafluprost
- tafluprost and dorzolamide/timolol
- (no location specified)
Dec 16, 2020
Neovascular Age-related Macular Degeneration, Wet Macular Degeneration Trial in United States (Dorzolamide-timolol, Artificial
Completed
- Neovascular Age-related Macular Degeneration
- Wet Macular Degeneration
- Dorzolamide-timolol
- Artificial tears
-
Palo Alto, California
- +4 more
Jun 5, 2020
Primary Open Angle Glaucoma, Ocular Hypertension Trial (PRO-122, Krytantek Ofteno®)
Completed
- Primary Open Angle Glaucoma
- Ocular Hypertension
- PRO-122
- Krytantek Ofteno®
- (no location specified)
Nov 20, 2019
Wet Macular Degeneration, Age-related Macular Degeneration, Diabetic Macular Edema Trial in Philadelphia (Dorzolamide-timolol)
Completed
- Wet Macular Degeneration
- +3 more
-
Philadelphia, PennsylvaniaWills Eye Hospital / Mid Atlantic Retina
Dec 1, 2019
Childhood Glaucoma Trial in Brescia, Catania (Latanoprost, Dorzolamide)
Completed
- Childhood Glaucoma
- Latanoprost, Dorzolamide
-
Brescia, Italy
- +1 more
Sep 11, 2019
Primary Open Angle Glaucoma, Ocular Hypertension Trial in Montemorelos (dorzolamide-timolol-brimonidine)
Completed
- Primary Open Angle Glaucoma
- Ocular Hypertension
-
Montemorelos, Nuevo Leon, MexicoInstituto de la Visión. Hospital Universitario La Carlota. Unive
Jun 6, 2019
Glaucoma Trial in Guadalajara (PRO-122, Krytantek Ofteno®)
Completed
- Glaucoma
- PRO-122
- Krytantek Ofteno®
-
Guadalajara, Jalisco, MexicoUnidad Clínica de Bioequivalencia, S. de R.L. de C.V.
Dec 12, 2019
Primary Open Angle Glaucoma of Both Eyes Trial in Kazan (Dorzotimol eye drops, 20 mg/mL + 5 mg/mL, Cosopt eye drops, 20 mg/mL +
Completed
- Primary Open Angle Glaucoma of Both Eyes
- Dorzotimol eye drops, 20 mg/mL + 5 mg/mL
- Cosopt eye drops, 20 mg/mL + 5 mg/mL
-
Kazan, Russian FederationRepublican Clinical Ophthalmological Hospital of the Ministry of
Jul 26, 2023
Primary Open Angle Glaucoma of Both Eyes Trial in Kazan (Dorzol 20 mg/ml, Trusopt 20 mg/ml)
Completed
- Primary Open Angle Glaucoma of Both Eyes
- Dorzol 20 mg/ml
- Trusopt 20 mg/ml
-
Kazan, Russian FederationState autonomous healthcare institution 'Republican Clinical Oph
Jul 26, 2023
Macular Hole, Retinal Detachment Trial in Philadelphia (Dorzolamide 2%-timolol 0.5% topical eyedrops)
Completed
- Macular Hole
- Retinal Detachment
- Dorzolamide 2%-timolol 0.5% topical eyedrops
-
Philadelphia, PennsylvaniaWills Eye Institute
Aug 13, 2019
Glaucoma, Open-Angle Trial (Brimonidine Tartrate, Dorzolamide (as Dorzolamide Hydrochloride) 20 Mg/mL and Timolol (as Timolol
Completed
- Glaucoma, Open-Angle
- Brimonidine Tartrate
- +5 more
- (no location specified)
May 24, 2019
Glaucoma Trial in Indianapolis (fixed combination of brimonidine tartrate 0.2% timolol maleate 0.5% ophthalmic solution, fixed
Completed
- Glaucoma
- fixed combination of brimonidine tartrate 0.2% timolol maleate 0.5% ophthalmic solution
- fixed combination of dorzolamide hydrochloride timolol maleate ophthalmic solution
-
Indianapolis, Indiana(unnamed)
Apr 10, 2019
Glaucoma, Ocular Surface Disease Trial in Thessaloniki (Assessment of ocular surface staining (Oxford score 0-15 scale), mean
Completed
- Glaucoma
- Ocular Surface Disease
- Assessment of ocular surface staining (Oxford score 0-15 scale)
- mean diurnal intraocular pressure-lowering
-
Thessaloniki, GreeceUniversity Department of Ophthalmology
Dec 16, 2020
Macular Edema, Inherited Retinal Dystrophy, Laser Retinopathy Trial in Rome (subthreshold treatment with micropulsed laser)
Not yet recruiting
- Macular Edema
- +2 more
- subthreshold treatment with micropulsed laser
-
Rome, RM, ItalyIRCSS Fondazione G:B:Bietti
Jul 27, 2023
Primary Open Angle Glaucoma, Ocular Hypertension Trial in Seoul (CKD-351, Latanoprost+Dorzolmamide)
Unknown status
- Primary Open Angle Glaucoma
- Ocular Hypertension
-
Seoul, Korea, Republic ofSeoul National University Hospital
Jun 24, 2020